H. Kerl

7.6k total citations · 1 hit paper
162 papers, 4.9k citations indexed

About

H. Kerl is a scholar working on Dermatology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, H. Kerl has authored 162 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Dermatology, 63 papers in Oncology and 34 papers in Pathology and Forensic Medicine. Recurrent topics in H. Kerl's work include Cutaneous Melanoma Detection and Management (45 papers), Cutaneous lymphoproliferative disorders research (37 papers) and Lymphoma Diagnosis and Treatment (19 papers). H. Kerl is often cited by papers focused on Cutaneous Melanoma Detection and Management (45 papers), Cutaneous lymphoproliferative disorders research (37 papers) and Lymphoma Diagnosis and Treatment (19 papers). H. Kerl collaborates with scholars based in Austria, Germany and Italy. H. Kerl's co-authors include H. Peter Soyer, Josef Smolle, Eggert Stockfleth, Lorenzo Cerroni, Wolfram Sterry, J. Roewert-Huber, Peter Wolf, Rein Willemze, Chris J.L.M. Meijer and Emilio Berti and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

H. Kerl

158 papers receiving 4.7k citations

Hit Papers

EORTC classification for ... 1997 2026 2006 2016 1997 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
H. Kerl 2.8k 2.0k 1.8k 1.4k 763 162 4.9k
Neil A. Fenske 1.9k 0.7× 2.6k 1.3× 1.8k 1.0× 631 0.4× 674 0.9× 163 5.7k
E Grosshans 2.0k 0.7× 785 0.4× 1.3k 0.8× 751 0.5× 675 0.9× 303 4.8k
Werner Kempf 4.3k 1.6× 1.9k 1.0× 3.1k 1.8× 2.8k 2.0× 1.1k 1.4× 293 7.3k
Patricia L. Myskowski 2.4k 0.9× 1.9k 1.0× 1.7k 0.9× 1.7k 1.2× 1.2k 1.5× 152 4.9k
Henry G. Skelton 1.4k 0.5× 1.1k 0.6× 1.3k 0.7× 445 0.3× 354 0.5× 163 3.8k
Christian A. Sander 1.4k 0.5× 1.0k 0.5× 665 0.4× 895 0.6× 1.1k 1.5× 91 3.3k
María Teresa Fernández‐Figueras 1.1k 0.4× 1.4k 0.7× 1.0k 0.6× 326 0.2× 830 1.1× 198 4.4k
G. Rassner 1.2k 0.4× 2.8k 1.4× 1.3k 0.7× 316 0.2× 715 0.9× 185 5.0k
Mauro Alaibac 1.1k 0.4× 994 0.5× 872 0.5× 690 0.5× 527 0.7× 191 3.0k
R. Cerio 1.1k 0.4× 1.0k 0.5× 1.1k 0.6× 554 0.4× 489 0.6× 146 3.4k

Countries citing papers authored by H. Kerl

Since Specialization
Citations

This map shows the geographic impact of H. Kerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kerl more than expected).

Fields of papers citing papers by H. Kerl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Kerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kerl. The network helps show where H. Kerl may publish in the future.

Co-authorship network of co-authors of H. Kerl

This figure shows the co-authorship network connecting the top 25 collaborators of H. Kerl. A scholar is included among the top collaborators of H. Kerl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Kerl. H. Kerl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schaider, Helmut, et al.. (2007). A signaling mute hCMV chemokine receptor prevents melanoma growth. Experimental Dermatology. 16(3). 262–263. 1 indexed citations
2.
Schaider, Helmut, et al.. (2006). The signaling mute hCMV chemokine receptor US28R129A prevents melanoma growth. Pharmacology. 78(3). 149–149. 1 indexed citations
3.
Zalaudek, Iris, Giuseppe Argenziano, Gerardo Ferrara, et al.. (2005). Melanoma. Guidelines for diagnosis and therapy (Das melarnom: Richtlinien fu?r diagnose und therapie). Queensland's institutional digital repository (The University of Queensland). 45(1). 35–52. 1 indexed citations
4.
Zalaudek, Iris, Andreas Blum, Giuseppe Argenziano, et al.. (2004). Age-related dermoscopic prevalence of Clark nevi. Journal of Investigative Dermatology. 123(2). 6–6.
5.
Soyer, H. Peter, et al.. (1996). Erythema migrans multiloculare in an European area endemic for Lyme borreliosis (Styria/Austria).. Journal of Investigative Dermatology. 106(4). 657–657. 1 indexed citations
6.
Wienecke, R., et al.. (1995). Molecular-Detection of Borrelia-Burgdorferi Specific Dna From Central and Peripheral Areas of Erythema Migrans. Journal of Investigative Dermatology. 104(4). 686–686. 2 indexed citations
7.
Soyer, H. Peter, et al.. (1995). Molecular Subtyping of Borrelia-Burgdorferi (Bb) in Lesional Skin From Styrian (Austrian) Patients with Various Manifestations of Dermatoborreliosis (Db). Journal of Investigative Dermatology. 104(4). 687–687. 6 indexed citations
8.
Cerroni, Lorenzo, H. Peter Soyer, & H. Kerl. (1995). Expression of Bcl-2 Protein (Bcl-2) in Cutaneous Neoplasms - An Immunohistochemical Study of 259 Benign and Malignant-Tumors of the Skin. European Journal of Dermatology. 5(7). 619–624. 3 indexed citations
9.
Soyer, H. Peter, et al.. (1994). No Detection of Borrelia-Burgdorferi Specific Dna in Lesions of Erythema Migrans After Treatment with Minocycline. Journal of Investigative Dermatology. 102(4). 615–615. 11 indexed citations
10.
Soyer, H. Peter & H. Kerl. (1993). [Surface microscopy of pigmented cutaneous tumors].. PubMed. 120(1). 15–20. 19 indexed citations
11.
Hofmann‐Wellenhof, R, Regina M. Kofler, H. Peter Soyer, H. Kerl, & Josef Smolle. (1992). Cell Motility Calculated by Computer-Simulation Is a Prognostic Parameter in Malignant-Melanoma. Journal of Investigative Dermatology. 98(4). 540–540. 1 indexed citations
12.
Volkenandt, Matthias, R. Wienecke, Jan Buer, et al.. (1992). Detection of Monoclonal Lymphoid Subpopulations in Clinical Specimens by Pcr and Conformational Polymorphisms of Crna Molecules. Journal of Investigative Dermatology. 98(4). 508–508. 4 indexed citations
13.
Fischer‐Colbrie, Reiner, Kurt Werner Schmid, Hans G. Feichtinger, et al.. (1988). Immunological Studies on the Occurrence and Properties of Chromogranin A and B and Secretogranin II in Endocrine Tumors. The American Journal of Surgical Pathology. 12(11). 877–884. 92 indexed citations
14.
Smolle, Josef, et al.. (1988). Alpha-interferon treatment of cutaneous pseudolymphoma - modulation of the dermal infiltrate. Journal of Investigative Dermatology. 90(2). 240–240. 4 indexed citations
15.
Soyer, H. Peter, et al.. (1988). Tubulin Expression in Melanocytic Skin Tumors. Journal of Cutaneous Pathology. 15(5). 344–344. 1 indexed citations
16.
Soyer, H. Peter, et al.. (1987). Pigmented Skin-Lesions in Xeroderma Pigmentosum. Journal of Cutaneous Pathology. 14(6). 372–372. 7 indexed citations
17.
Smolle, Josef, et al.. (1987). Hla-Dr Positive Keratinocytes Are Associated with Suppressor-Cell Epidermotropism - a Biomathematical Study. Journal of Investigative Dermatology. 89(4). 450–450. 7 indexed citations
18.
Smolle, Josef, et al.. (1986). Nk Cell-Density in Malignant Skin Tumors - a Stereological Study. Journal of Investigative Dermatology. 87(1). 168–168. 1 indexed citations
19.
Smolle, Josef, et al.. (1986). Significance of “accessory” cells in malignant lymphomas and pseudolymphomas of the skin. Journal of Investigative Dermatology. 86(3). 336. 11 indexed citations
20.
Soyer, H. Peter, et al.. (1986). Impact of PET/CT on initial staging, restaging and treatment management of anal cancer: a clinical case with literature review.. Journal of Investigative Dermatology. 11(3). 335–336. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026